Castrow F F, Krull E A
J Am Acad Dermatol. 1983 Dec;9(6):889-93. doi: 10.1016/s0190-9622(83)70204-5.
Injectable collagen implant (ICI), a new biomaterial reportedly useful for correction of scars and certain aging skin lines (wrinkles), was recently introduced. The purpose of this paper is to evaluate the safety and efficacy of this product. Data for this study were obtained from a survey which was sent to a group of cutaneous surgeons. They were asked about test site and treatment site reactions and about their satisfaction with ICI. The incidence of adverse reactions is low, and the severity of the reactions does not appear to be serious. The long-term benefit of ICI has not been established.
可注射胶原蛋白植入物(ICI)是一种据报道可用于修复疤痕和某些皮肤老化纹路(皱纹)的新型生物材料,最近已被引入。本文的目的是评估该产品的安全性和有效性。本研究的数据来自一项发送给一组皮肤科外科医生的调查。他们被问及测试部位和治疗部位的反应以及对ICI的满意度。不良反应的发生率较低,且反应的严重程度似乎并不严重。ICI的长期益处尚未得到证实。